TRP_1170x120_3-8-19

Brendan O’Grady

Teva Announces Launch of an authorized generic of Flector 1 Patch 1.3%

Teva Announces Launch of an authorized generic of Flector 1 Patch 1.3%

JERUSALEM — Teva Pharmaceutical Industries announced the launch of an authorized generic of Flector 1 Patch, 1.3%, in the U.S. Diclofenac epolamine topical patch, 1.3%, a non-steroidal anti-inflammatory drug (NSAID), is indicated for the topical treatment of acute pain due to minor strains, sprains and contusions. “The launch of our authorized generic of Flector Patch

Teva’s generic epinephrine injection now available in limited quantity in the U.S.

Teva’s generic epinephrine injection now available in limited quantity in the U.S.

PARSIPPANY, N.J. — Teva Pharmaceutical Industries announced the release of limited doses of the FDA-approved generic version of EpiPen (epinephrine injection, USP) Auto-Injector, 0.3 mg, in the U.S. Teva’s generic version of the EpiPen Jr (epinephrine injection, USP) Auto-Injector, 0.15 mg, and an additional supply of Teva’s generic version of the EpiPen (epinephrine injection, USP) Auto-Injector,

Teva rolls out QVAR RediHaler in U.S.

Teva rolls out QVAR RediHaler in U.S.

JERUSALEM, Israel — Teva Pharmaceutical Industries Ltd. has made its QVAR RediHaler Inhalation Aerosol (beclomethasone dipropionate HFA) commercially available in 40-mcg and 80-mcg strengths in the United States. The QVAR RediHaler is the first and only breath-actuated aerosol inhaled corticosteroid for the maintenance treatment of asthma as a prophylactic therapy in patients ages 4 years and older,

Teva, Greenstone roll out Viagra generics in U.S.

Teva, Greenstone roll out Viagra generics in U.S.

NEW YORK — The first generic versions of Viagra, Pfizer Inc.’s blockbuster drug for erectile dysfunction, were launched this week in the United States by Teva Pharmaceutical Industries Ltd. and Greenstone LLC. Israel-based Teva said it’s offering sildenafil citrate tablets in dosages of 25 mg, 50 mg and 100 mg. Greenstone, a Peapack, N.J.-based Pfizer subsidiary,

Teva unveils reorganization plan

Teva unveils reorganization plan

  JERUSALEM, Israel — Just over two months after naming a new chief executive officer, Teva Pharmaceutical Industries Ltd., the world’s largest maker of generic drugs, is reorganizing its business and leadership structure. Teva said Monday that it’s integrating its drug businesses into one commercial organization, and there will no longer be two separate global

Mylan, Teva roll out generic versions of Intuniv

Mylan, Teva roll out generic versions of Intuniv

NEW YORK — Mylan N.V. and Teva Pharmaceutical Industries Ltd. have released guanfacine extended-release tablets, a nonstimulant medication for attention deficit hyperactivity disorder (ADHD), in the United States. The pharmaceutical companies said Tuesday that their products, available in strengths of 1 mg, 2 mg, 3 mg and 4 mg, are generic equivalents of Intuniv from